Abstract: An electric stimulation device includes a main body portion having a stimulation electrode stimulating nerves or muscles inside the living body, a stimulation circuit portion with a stimulation circuit electrically connected to the stimulation electrode and applying a stimulation signal to the stimulation electrode, and a support body connected to the stimulation circuit portion and holding the implant position of the stimulation electrode inside the living body. The electric stimulation device also includes a fixing body connectable to the base end portion of the main body portion. The fixing body includes a fixing body side coil portion that receives an electromagnetic wave transmitted from an external device. When the fixing body is connected to the main body portion, the fixing body side coil portion is electrically connected to the stimulation circuit to enable power feeding and/or communication with respect to the stimulation circuit in response to the electromagnetic wave.

Abstract: An electric stimulator includes a stimulation circuit block having a stimulation electrode that stimulates nerves or muscles in a living body and a stimulation circuit that is electrically connected to the stimulation electrode to apply a stimulation signal to the stimulation electrode. Additionally, the electric stimulator further includes a support that is connected to the stimulation circuit block to hold the stimulation electrode at an implantation position in the living body. The stimulation circuit block and the support, except for at least one end of the support, have a shape configured to be inserted into the duct of a tubular insertion tool.

Abstract: Precursor of fatal arrhythmia is detected and by setting the tolerance level for carrying out nerve stimulation depending on the severity degree of the precursor, significant variation of the heart rate is suppressed and induction of the fatal arrhythmia is repressed. For this purpose, precursor of tachyarrhythmia occurrence such as premature contraction, ST change, repolarization abnormality or the like is detected and the lower-limit of the atrium interval which becomes the tolerance level of the nerve stimulation is set according to the detected result. Then, it is constituted according to the precursor of aforesaid tachyarrhythmia such that time for making the nerve stimulation means in an operation state is to be adjusted or nerve stimulation is to be carried out as much as the heart rate of a predetermined number of times.

Abstract: Heart treatment equipment and a heart treatment method directed to prevention of a fatal arrhythmia by detecting a physical exercise or a mental stress by using a sensor and thereafter controlling the vagus nerve stimulation, wherein sensor means for detecting various living body information for generating a signal which designates degree of a sympathetic tone is provided and heart rate threshold for carrying out the vagus nerve stimulation is adjusted according to the living body information detected by the sensor means. Further, a nerve stimulation parameter for adjusting the strength of the vagus nerve stimulation is adjusted in response to the degree of the patient sympathetic tone.

Abstract: In a heart treatment equipment provided with a stimulating mechanism for both the ventricles, the both ventricle stimulation is made optimized in order to inhibit the decrease of the cardiac output when a heart rate increase or the vagus nerve stimulation is performed and the equipment comprises a right ventricle pulse generator for stimulation the right ventricle, a left ventricle pulse generator for stimulation the left ventricle, wherein the controller for selecting either one of aforesaid right ventricle pulse generator and left ventricle pulse generator or selecting both of them for the ventricle stimulation is constituted such as to select both of the right ventricle pulse generator and the left ventricle pulse generator in response to the vagus nerve stimulation or the heart rate monitor output.

Abstract: In order to avoid a sudden cardiac death by a fatal arrhythmia, various living body information for generating a signal which shows a level of an autonomic tone is detected by a sensor or a VT/VF risk event is detected so as to control the stimulation of the vagus nerve or the nerve stimulation waveform. For this purpose, the parameter of the nerve stimulation signal is controlled according to a detection of the living body information represented by a QT interval which is measured by intracardiac information of the heart or a detection of a VT/VF risk event represented by a ventricular premature contraction which is picked up from spontaneous cardiac events.

Abstract: Precursor of fatal arrhythmia is detected and by setting the tolerance level for carrying out nerve stimulation depending on the severity degree of the precursor, significant variation of the heart rate is suppressed and induction of the fatal arrhythmia is repressed. For this purpose, precursor of tachyarrhythmia occurrence such as premature contraction, ST change, repolarization abnormality or the like is detected and the lower-limit of the atrium interval which becomes the tolerance level of the nerve stimulation is set according to the detected result. Then, it is constituted according to the precursor of aforesaid tachyarrhythmia such that time for making the nerve stimulation means in an operation state is to be adjusted or nerve stimulation is to be carried out as much as the heart rate of a predetermined number of times.

Abstract: There is disclosed heart treatment equipment in which it is possible to carry out controlling of a preventive treatment after an anti-tachyarrhthmia treatment in order to execute prevention and treatment of a fatal arrhythmia and the anti-tachyarrhythmia treatment is carried out by controlling tachyarrhythmia prevention means and tachyarrhythmia treatment means (tachyarrhythmia termination means) according to the result of detecting occurrence of tachyarrhythmia. In the anti-tachyarrhythmia treatment, there is provided with a structure for reducing or stopping the activation current with respect to the vagus nerve or a repression current with respect to the sympathetic nerve after a supply of an electroshock to the heart such as cardioversion, defibrillation or the like, so that it is possible to prevent deterioration of hemodynamics, recurrence of fatal arrhythmia and supraventicular arrhythmia such as atrial fibrillation or the like.

Abstract: In order to avoid a sudden cardiac death by a fatal arrhythmia, various living body information for generating a signal which shows a level of an autonomic tone is detected by a sensor or a VT/VF risk event is detected so as to control the stimulation of the vagus nerve or the nerve stimulation waveform. For this purpose, the parameter of the nerve stimulation signal is controlled according to a detection of the living body information represented by a QT interval which is measured by intracardiac information of the heart or a detection of a VT/VF risk event represented by a ventricular premature contraction which is picked up from spontaneous cardiac events.

Abstract: Heart treatment equipment and a heart treatment method directed to prevention of a fatal arrhythmia by detecting a physical exercise or a mental stress by using a sensor and thereafter controlling the vagus nerve stimulation, wherein sensor means for detecting various living body information for generating a signal which designates degree of a sympathetic tone is provided and heart rate threshold for carrying out the vagus nerve stimulation is adjusted according to the living body information detected by the sensor means. Further, a nerve stimulation parameter for adjusting the strength of the vagus nerve stimulation is adjusted in response to the degree of the patient sympathetic tone.

Abstract: In order to avoid a sudden cardiac death by a fatal arrhythmia, various living body information for generating a signal which shows a level of an autonomic tone is detected by a sensor or a VT/VF risk event is detected so as to control the stimulation of the vagus nerve or the nerve stimulation waveform. For this purpose, the parameter of the nerve stimulation signal is controlled according to a detection of the living body information represented by a QT interval which is measured by intracardiac information of the heart or a detection of a VT/VF risk event represented by a ventricular premature contraction which is picked up from spontaneous cardiac events.